YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 12, Pages 1541-1553
Publisher
Springer Nature
Online
2015-06-29
DOI
10.1038/onc.2015.219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models
- (2014) E. Ciamporcero et al. MOLECULAR CANCER THERAPEUTICS
- In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth
- (2014) N Jiang et al. ONCOGENE
- CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
- (2014) Hsiao-Chi Tsai et al. PLoS One
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
- (2013) Jian-Ye Liu et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
- (2013) Xue-Pu Sun et al. FEBS Journal
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- Abstract 3321: Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma
- (2012) Chian-Shiu Chien et al. CANCER RESEARCH
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14
- (2012) J-M Huang et al. ONCOGENE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
- (2011) J. B. Shah et al. CLINICAL CANCER RESEARCH
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
- (2011) Yukako Imanaka et al. JOURNAL OF HUMAN GENETICS
- Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
- (2011) A Fernandez-L et al. ONCOGENE
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma
- (2011) Sebastian Reichert et al. RADIOTHERAPY AND ONCOLOGY
- Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
- (2010) C. A. Hall et al. CANCER RESEARCH
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets
- (2010) R Ehsanian et al. ONCOGENE
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
- (2009) M.-Y. Wang et al. CANCER RESEARCH
- The comet assay: A sensitive method for detecting DNA damage in individual cells
- (2009) Wenjuan Liao et al. METHODS
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started